Status:
COMPLETED
Disease Modification in Toxaemia of Pregnancy
Lead Sponsor:
University of British Columbia
Conditions:
Pre-eclampsia
Eligibility:
FEMALE
18-40 years
Brief Summary
Short description of the primary purpose of the protocol intended for the lay public. Include brief statement of study hypothesis Pre-eclampsia (toxemia of pregnancy) is the most cause of death among...
Eligibility Criteria
Inclusion
- Scenario 1 is severe early-onset pre-eclampsia, where the fetal prognosis is dismal (\<50% chance of intact survival \[disease onset \<27+0 weeks gestation and/or estimated fetal weight \<600g\].
- Scenario 2 is postpartum pre-eclampsia, where there is either severe antenatal disease, deteriorating postpartum disease, or de novo postpartum disease.
Exclusion
- \-
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00175695
Start Date
December 1 2004
End Date
October 1 2010
Last Update
February 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Women's Hospital and Health Centre
Vancouver, British Columbia, Canada, V6H 3N1